- Fremanezumab in migraine treatment - optimal patient selection2020 | First Faculty of Medicine
- Komentář ke druhé interní analýze evropské observační studie účinnosti fremanezumabu – PEARL2023 | First Faculty of Medicine
- CGRP monoclonal antibodies for migraine prophylaxis2019 | First Faculty of Medicine
- Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study2023 | First Faculty of Medicine
- Komentář ke studii2020 | First Faculty of Medicine
- CGRP antibodies in the prophylactic treatment of migraine2022 | First Faculty of Medicine
- From pathophysiology of migraine to monoclonal antibodies2019 | Faculty of Medicine in Pilsen
- Primary headaches - treatment today and tomorrow2018 | Faculty of Medicine in Pilsen
- Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index2022 | First Faculty of Medicine, Faculty of Physical Education and Sport